Antimicrobial Susceptibility Distributions of Clinical Isolates of Nontuberculous Mycobacteria in Israel

Keyphrases

• Active Agent 50%
• Amikacin 50%
• Antimicrobial Susceptibility 100%
• Antimicrobial Susceptibility Profile 25%
• Broth Microdilution 25%
• Clarithromycin 50%
• Gene Sequencing 25%
• Hsp65 Gene 25%
• Isolated Species 25%
• Israel 100%
• Linezolid 50%
• Matrix-assisted Laser Desorption Ionization-time of Flight Mass Spectrometry (MALDI-TOF MS) 25%
• Middle Eastern Countries 25%
• Minimum Inhibitory Concentration 25%
• Moxifloxacin 25%
• Mycobacterium Abscessus 50%
• Mycobacterium Avium Complex 50%
• Mycobacterium Chelonae 25%
• Mycobacterium Fortuitum 50%
• Mycobacterium Kansasii 50%
• Mycobacterium Simiae 50%
• Mycobacterium Tuberculosis (M. tb) 100%
• Nontuberculous Mycobacterial Infection 25%
• Rapidly Growing Mycobacteria 100%
• Sensititre 25%
• Species Level 25%
• Susceptibility Distribution 100%
• Testing Profile 25%

Immunology and Microbiology

• Antibiotic Sensitivity 100%
• Broth Dilution 33%
• Gene Sequence 33%
• Matrix-Assisted Laser Desorption-Ionization 33%
• Minimum Inhibitory Concentration 33%
• Mycobacteria 66%
• Mycobacterium abscessus 33%
• Mycobacterium Avium Complex 66%
• Mycobacterium fortuitum 33%
• Mycobacterium kansasii 33%
• Mycobacterium simiae 33%
• Nontuberculous mycobacteria 100%
• Slowly Growing Mycobacteria 66%
• Time-of-Flight Mass Spectrometry 33%